ReviewEfficacy of polyphenolic ingredients of Chinese herbs in treating dyslipidemia of metabolic syndromes
References (89)
- et al.
Rapid regression of atherosclerosis with MTP inhibitor treatment
Atherosclerosis
(2013) - et al.
Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins
J Lipid Res
(2012) - et al.
Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL
J Lipid Res
(2009) - et al.
Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver
J Biol Chem
(2004) - et al.
PCSK9 function and physiology
J Lipid Res
(2008) - et al.
The dark side of sexual selection
Trends Ecol Evol
(1999) - et al.
Hepatic trans-Golgi action coordinated by the GTPase ARFRP1 is crucial for lipoprotein lipidation and assembly
J Lipid Res
(2014) - et al.
GPIHBP1, an endothelial cell transporter for lipoprotein lipase
J Lipid Res
(2011) - et al.
Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects
Atherosclerosis
(2004) - et al.
Lipolysis and lipid mobilization in human adipose tissue
Prog Lipid Res
(2009)
Challenges and opportunities of defining clinical leptin resistance
Cell Metab
(2012)
Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues
Biochem Biophys Res Commun
(1997)
Selective versus total insulin resistance: a pathogenic paradox
Cell Metab
(2008)
Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum
J Biol Chem
(1997)
Berberine inhibits adipogenesis in high-fat diet-induced obesity mice
Fitoterapia
(2010)
Efficacy of berberine in patients with type 2 diabetes mellitus
Metabolism
(2008)
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
Metabolism
(2010)
Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes
Eur J Pharmacol
(2010)
Hepatocyte nuclear factor 1α plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine
J Biol Chem
(2009)
Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver X receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters
Biol Pharm Bull
(2011)
Berberine inhibits PTP1B activity and mimics insulin action
Biochem Biophys Res Commun
(2010)
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK
Biochim Biophys Acta
(2006)
Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats
J Lipid Res
(2010)
Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells
Fitoterapia
(2014)
Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect
J Nutr Biochem
(2007)
Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters
Metabolism
(2008)
Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans
Circ Res
(2013)
Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism
Curr Opin Lipidol
(2008)
FDA approves Aegerion Pharmaceuticals’ JUXTAPID™ (lomitapide) Capsules for homozygous familial hypercholesterolemia (HoFH). (2012-12-24) [2013-6-15]
Intrahepatic role of exchangeable apolipoproteins in lipoprotein assembly and secretion
Arterioscler Thromb Vasc Biol
(2012)
Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production
Curr Opin Lipidol
(2012)
Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia
Nat Clin Pract Cardiovasc Med
(2008)
The LDL receptor
Arterioscler Thromb Vasc Biol
(2009)
Inhibition of PCSK9: a powerful weapon for achieving ideal LDL cholesterol levels
Proc Natl Acad Sci U S A
(2009)
Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I
J Clin Invest
(2005)
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.
J Clin Invest
(2007)
Transport of lipids from Golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice
Nat Genet
(2000)
Merck: niacin drug mix fails to prevent heart attacks, strokes. (2012-12-20) [2013-6-20]
Genetic defenses against noncholesterol sterols
Curr Opin Lipidol
(2003)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
Science
(2004)
The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1)
Proc Natl Acad Sci U S A
(2005)
Combination therapy in cholesterol reduction: focus on ezetimibe and statins
Vasc Health Risk Manag
(2008)
MTP inhibition as a treatment for dyslipidemias: time to deliver or empty promises?
Expert Opin Ther Targets
(2007)
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders
Nat Genet
(2003)
Cited by (0)
Copyright © 2014 Journal of Integrative Medicine Editorial Office. E-edition published by Elsevier (Singapore) Pte Ltd. All rights reserved. Published by Elsevier B.V. All rights reserved.